Acro Biomedical (ACBM) Return on Capital Employed (2017 - 2025)
Acro Biomedical's quarterly Return on Capital Employed came in at 39.31% in Q4 2025, up 3626.0% year-on-year from 1.05% in Q4 2024, and up 35.91% quarter-over-quarter from 28.92% in Q3 2025.
Acro Biomedical has reported Return on Capital Employed for 9 years, with the latest figure at 39.31% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed rose 3626.0% year-over-year to 39.31%; the trailing twelve-month figure through Dec 2025 stood at 39.31% (up 3626.0% YoY), and the FY2025 full-year result was 40.74%, up 3759.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 39.31%, up from 28.92% in the prior quarter.
- The five-year high for Return on Capital Employed was 740.33% in Q4 2023, with the low at 62212.3% in Q3 2023.
- Average Return on Capital Employed over 5 years is 4352.18%, with a median of 1077.9% recorded in 2024.
- Year-over-year, Return on Capital Employed tumbled 5912579 bps in 2023 and surged 5970295 bps in 2024.
- Tracing ACBM's Return on Capital Employed over 5 years: stood at 1274.19% in 2021, then plunged by 168 bps to 3416.88% in 2022, then jumped by 122 bps to 740.33% in 2023, then plunged by 100 bps to 3.05% in 2024, then surged by 1191 bps to 39.31% in 2025.
- The last three Return on Capital Employed figures came in at 39.31% (Q4 2025), 28.92% (Q3 2025), and 3.63% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -0.25% |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -0.36% |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -0.22% |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -1.56% |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -1.55% |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -3.13% |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -0.36% |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -0.69% |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -0.23% |
| 10 | Acro Biomedical | - | - | - | 39.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.31% |
| Sep 30, 2025 | 28.92% |
| Jun 30, 2025 | 3.63% |
| Mar 31, 2025 | 2.50% |
| Dec 31, 2024 | 3.05% |
| Sep 30, 2024 | -2,509.35% |
| Jun 30, 2024 | -2,049.79% |
| Mar 31, 2024 | -881.61% |
| Dec 31, 2023 | 740.33% |
| Sep 30, 2023 | -62,212.30% |
| Jun 30, 2023 | -3,799.53% |
| Mar 31, 2023 | -3,741.32% |
| Dec 31, 2022 | -3,416.88% |
| Sep 30, 2022 | -3,086.51% |
| Jun 30, 2022 | -2,391.60% |
| Mar 31, 2022 | -1,703.65% |
| Dec 31, 2021 | -1,274.19% |
| Sep 30, 2021 | -648.32% |
| Jun 30, 2021 | -129.65% |
| Mar 31, 2021 | -16.67% |
| Sep 30, 2020 | -17.01% |
| Jun 30, 2020 | -14.46% |
| Mar 31, 2020 | -14.83% |
| Dec 31, 2019 | -47.54% |
| Sep 30, 2019 | -50.21% |
| Jun 30, 2019 | -22.10% |
| Mar 31, 2019 | 2.66% |
| Dec 31, 2018 | 26.78% |
| Sep 30, 2018 | 51.26% |
| Jun 30, 2018 | 55.78% |
| Mar 31, 2018 | 33.78% |
| Dec 31, 2017 | 17.66% |
| Sep 30, 2017 | -0.94% |